Pharmacological coronary spasm provocative testing in clinical practice: A French Coronary Atheroma and Interventional Cardiology Group (GACI) position paper - Institut de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition Access content directly
Journal Articles Archives of cardiovascular diseases Year : 2023

Pharmacological coronary spasm provocative testing in clinical practice: A French Coronary Atheroma and Interventional Cardiology Group (GACI) position paper

Abstract

Highlights  •VSA is common and is involved in many clinical scenarios.  •These include chronic and acute coronary syndromes, SCD, arrhythmia and syncope.  •VSA is underdiagnosed and provocative tests are rarely performed.  •A lack of uniform protocol decreases the use and performance of provocative tests.  •This accounts for VSA underestimation.  •This GACI position paper gives clear indications for provocative tests.  •The paper also addresses testing conditions, drug protocols and positivity criteria.
Fichier principal
Vignette du fichier
Skip to main contentSkip to article 3.pdf (358.4 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04380263 , version 1 (08-01-2024)

Identifiers

Cite

Fabien Picard, Julien Adjedj, Jean-Philippe Collet, Eric van Belle, Jacques Monsegu, et al.. Pharmacological coronary spasm provocative testing in clinical practice: A French Coronary Atheroma and Interventional Cardiology Group (GACI) position paper. Archives of cardiovascular diseases, 2023, 116 (12), pp.590-596. ⟨10.1016/j.acvd.2023.10.002⟩. ⟨hal-04380263⟩
44 View
18 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More